27/04/2020

COVID-19: communication to Partners, Customers and Suppliers,

Health and safety, a top priority for Fidia

According to Fidia Farmaceutici S.p.A mission and policy, health and safety of people, and of course of our employees, are absolute priority.

This is why we decided to reduce potential risks, asking our colleagues, partners, visitors, ecc… to work remotely as much as possible, as well as to strictly follow all the rules our Government has recently published.

As a consequence, we are either postponing or organizing meetings to take place digitally, in order to guarantee usual working activities, until the risk of infection is minimized

This is not affecting our working activities, thus we guarantee full operations in, from and to the factories.

Also, all transports of goods, in Italy and to foreign countries are guaranteed and operations proceed at normal capacity/as planned. In addition to this, at present we do not foresee any issue related to the supply of materials from our suppliers.

We are sure you all agree on the precautions we are taking in this emergency period, and we will share updates when new information or guidelines need to be communicated.

Best regards

Carlo Pizzocaro
CEO Fidia Farmaceutici S.p.A.

Health
Products
Website

Find out more about Fidia’s product portfolio:

Go to the website

Key Business Areas

Fidia operates in numerous therapeutic areas, providing specific, innovative treatments for commonly occurring pathologies with major socio-economic impact, namely:

- joint care
- ophthalmology
- active wound care
- neuroscience
- aesthetic medicine